Ocular Therapeutix (OCUL) Inventory (2014 - 2026)
Ocular Therapeutix's quarterly Inventory came in at $3.7 million in Q1 2026, up 14.32% year-on-year from $3.3 million in Q1 2025, and up 4.85% quarter-over-quarter from $3.6 million in Q4 2025.
Ocular Therapeutix has reported Inventory for 13 years, with the latest figure at $3.7 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 14.32% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (up 14.32% YoY), and the FY2025 full-year result was $3.6 million, up 17.24% from the prior year.
- Inventory for Q1 2026 stood at $3.7 million, up from $3.6 million in the prior quarter.
- The five-year high for Inventory was $3.7 million in Q1 2026, with the low at $1.4 million in Q1 2022.
- Average Inventory over 5 years is $2.5 million, with a median of $2.4 million recorded in 2024.
- Year-over-year, Inventory surged 66.86% in 2023 and climbed 6.56% in 2024.
- Tracing OCUL's Inventory over 5 years: stood at $2.0 million in 2022, then gained by 16.77% to $2.3 million in 2023, then jumped by 31.89% to $3.0 million in 2024, then increased by 17.24% to $3.6 million in 2025, then climbed by 4.85% to $3.7 million in 2026.
- The last three Inventory figures came in at $3.7 million (Q1 2026), $3.6 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | 3.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.74 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 3.04 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 2.26 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 1.11 Mn |
| Mar 31, 2021 | 1.12 Mn |
| Dec 31, 2020 | 1.20 Mn |
| Sep 30, 2020 | 1.15 Mn |
| Jun 30, 2020 | 1.07 Mn |
| Mar 31, 2020 | 1.11 Mn |
| Dec 31, 2019 | 954,000.00 |
| Sep 30, 2019 | 895,000.00 |
| Jun 30, 2019 | 762,000.00 |
| Mar 31, 2019 | 265,000.00 |
| Dec 31, 2018 | 217,000.00 |
| Sep 30, 2018 | 102,000.00 |
| Jun 30, 2018 | 131,000.00 |
| Mar 31, 2018 | 139,000.00 |
| Dec 31, 2017 | 122,000.00 |
| Sep 30, 2017 | 127,000.00 |
| Jun 30, 2017 | 90,000.00 |
| Mar 31, 2017 | 96,000.00 |
| Dec 31, 2016 | 113,000.00 |
| Sep 30, 2016 | 126,000.00 |
| Jun 30, 2016 | 149,000.00 |
| Mar 31, 2016 | 127,000.00 |
| Dec 31, 2015 | 134,000.00 |
| Sep 30, 2015 | 147,000.00 |
| Jun 30, 2015 | 145,000.00 |
| Mar 31, 2015 | 158,000.00 |
| Dec 31, 2014 | 133,000.00 |
| Sep 30, 2014 | 117,000.00 |
| Jun 30, 2014 | 109,000.00 |